These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17825396)

  • 1. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstaging of cervical cancer.
    Ananth R
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker.
    Bhatla N; Mukhopadhyay A; Joshi S; Kumar A; Kriplani A; Pandey RM; Verma K
    Indian J Cancer; 2004; 41(1):32-6. PubMed ID: 15105577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer control in developing countries: memorandum from a WHO meeting.
    Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low cost methods for secondary prevention of cervical cancer in developing countries.
    Anorlu RI; Ola ER; Abudu OO
    Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization for cervical cancer screening: lessons from a poor-urban Yoruba community in Nigeria.
    Thomas JO; Babarinsa IA; Ajayi IO; Fawole O; Ojemakinde KO; Omigbodun AO
    Afr J Med Med Sci; 2005 Mar; 34(1):81-5. PubMed ID: 15973782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou screening in developing countries: an idea whose time has come.
    Suba EJ; Raab SS;
    Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New adjunctive methods for cervical cancer screening.
    Schneider A; Zahm DM
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):657-73. PubMed ID: 8869951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
    Gaikwad NL; Mahajan NN; Mahajan KN
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):258-9; author reply 259. PubMed ID: 17550500
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria.
    Miller D; Okolo CA; Mirabal Y; Guillaud M; Arulogun OS; Oladepo O; Crain B; Follen M; Adewole IF
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S196-207. PubMed ID: 17889285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: screening and therapeutic perspectives.
    Sankaranarayanan R; Thara S; Esmy PO; Basu P
    Med Princ Pract; 2008; 17(5):351-64. PubMed ID: 18685274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cervical cancer screening for prevention of carcinoma cervix.
    Christe DM; Mohanambal M; Ramamurthy V; Snehaa NB
    J Indian Med Assoc; 2008 Dec; 106(12):779-80, 782. PubMed ID: 19370947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to cervical cancer screening in Latin America and the Caribbean.
    Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
    Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mobile-phone based high-resolution microendoscope to image cervical precancer.
    Grant BD; Quang T; Possati-Resende JC; Scapulatempo-Neto C; de Macedo Matsushita G; Mauad EC; Stoler MH; Castle PE; Guerreiro Fregnani JHT; Schmeler KM; Richards-Kortum R
    PLoS One; 2019; 14(2):e0211045. PubMed ID: 30726252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.